Press-release for stocks publishing date 2021 - 12

Prices are updated after-hours

Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 and ARCT-165 Clinical Trials
Published: 2021-12-16 (Crawled : 14:00) - biospace.com/
TAK | News | $13.16 0.08% 0.15% 2.1K

| -2.88% | O: 1.18% H: 0.0% C: 0.0%
JNJ | News | $145.74 0.67% -0.36% 8.1K

| -14.83% | O: 0.59% H: 0.0% C: 0.0%
ARCT 4 | $26.32 -4.78% -5.06% 0

| -23.4% | O: 10.59% H: 17.58% C: 13.16%
arct-154 als trials trial therapeutics clinical trials

Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Published: 2021-12-16 (Crawled : 05:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.15% 2.1K

| -2.88% | O: 1.18% H: 0.0% C: 0.0%
NVAX | $3.89 0.26% 16K

| -97.71% | O: 5.55% H: 0.0% C: 0.0%
covid-19 new drug application drug approval covid vaccine submission

67%

33%

AGBA | News | $1.4 250.0% 35M

ZCMD | $2.18 50.35% 24M

RWOD | $12.0 50.06% 3.9M

AULT | $0.3174 31.1% 28M

WISA 4 | $7.11 20.71% 4.7M

INDO | $4.9 20.1% 2.2M

LIFW | News | $0.99 19.26% 800K

PRTG | $0.285 18.75% 140K

NURO | $4.32 18.36% 66K

HUBC | $1.52 17.83% 4.7M

Save your searches and get alerts when important news are released.